Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson's disease model

被引:2
|
作者
Alwani, Anna [1 ]
Maziarz, Katarzyna [1 ]
Lyszczarz, Gabriela [1 ]
Jankowska-Kieltyka, Monika [1 ]
Roman, Adam [1 ]
Lyszczarz, Gabriela [1 ]
Er, Safak [2 ,3 ]
Barut, Justyna [1 ]
Barczyk-Woznicka, Olga [4 ]
Pyza, Elzbieta [4 ]
Kreiner, Grzegorz [1 ]
Nalepa, Irena [1 ]
Chmielarz, Piotr [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Brain Biochem, Smetna 12, PL-31343 Krakow, Poland
[2] Univ Helsinki, Drug Res Program, Fac Pharm, Helsinki, Finland
[3] Univ Helsinki, HiLIFE, Inst Biotechnol, Helsinki, Finland
[4] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Cell Biol & Imaging, Gronostajowa 9, PL-30387 Krakow, Poland
基金
芬兰科学院;
关键词
alpha-synuclein; Preformed fibrils; Parkinson's disease; Non-motor symptoms; Depression; Chronic stress; LEWY BODIES; DEPRESSIVE-LIKE; AMYGDALA; MICE; BODY; NEURODEGENERATION; COMPENSATION; PHENOTYPES; DEMENTIA; BEHAVIOR;
D O I
10.1007/s43440-023-00530-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Parkinson's disease (PD) is a motor disorder characterized by the degeneration of dopaminergic neurons, putatively due to the accumulation of alpha-synuclein (alpha-syn) in Lewy bodies (LBs) in Substantia Nigra. PD is also associated with the formation of LBs in brain areas responsible for emotional and cognitive regulation such as the amygdala and prefrontal cortex, and concurrent depression prevalence in PD patients. The exact link between dopaminergic cell loss, alpha-syn aggregation, depression, and stress, a major depression risk factor, is unclear. Therefore, we aimed to explore the interplay between sensitivity to chronic stress and alpha-syn aggregation.Methods Bilateral injections of alpha-syn preformed fibrils (PFFs) into the striatum of C57Bl/6 J mice were used to induce alpha-syn aggregation. Three months after injections, animals were exposed to chronic social defeat stress.Results alpha-syn aggregation did not affect stress susceptibility but independently caused increased locomotor activity in the open field test, reduced anxiety in the light-dark box test, and increased active time in the tail suspension test. Ex vivo analysis revealed modest dopaminergic neuron loss in the substantia nigra and reduced dopaminergic innervation in the dorsal striatum in PFFs injected groups. alpha-Syn aggregates were prominent in the amygdala, prefrontal cortex, and substantia nigra, with minimal alpha-syn aggregation in the raphe nuclei and locus coeruleus.Conclusions Progressive bilateral alpha-syn aggregation might lead to compensatory activity increase and alterations in emotionally regulated behavior, without affecting stress susceptibility. Understanding how alpha-syn aggregation and degeneration in specific brain structures contribute to depression and anxiety in PD patients requires further investigation.
引用
收藏
页码:1474 / 1487
页数:14
相关论文
共 50 条
  • [21] The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease
    Yang, Kaixia
    Lv, Zhongyue
    Zhao, Wen
    Lai, Guogang
    Zheng, Cheng
    Qi, Feiteng
    Zhao, Cui
    Hu, Kaikai
    Chen, Xiao
    Fu, Fan
    Li, Jiayi
    Xie, Guomin
    Wang, Haifeng
    Wu, Xiping
    Zheng, Wu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease
    Hu, Qi
    Uversky, Vladimir N.
    Huang, Mengyang
    Kang, Huicong
    Xu, Feng
    Liu, Xiaoyan
    Lian, Lifei
    Liang, Qiming
    Jiang, Hong
    Liu, Anding
    Zhang, Cuntai
    Pan-Montojo, Francisco
    Zhu, Suiqiang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (10): : 1883 - 1890
  • [23] Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
    Yi-Qing Lv
    Lin Yuan
    Yan Sun
    Hao-Wen Dou
    Ji-Hui Su
    Zhi-Pan Hou
    Jia-Yi Li
    Wen Li
    Translational Neurodegeneration, 11
  • [24] Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
    Lv, Yi-Qing
    Yuan, Lin
    Sun, Yan
    Dou, Hao-Wen
    Su, Ji-Hui
    Hou, Zhi-Pan
    Li, Jia-Yi
    Li, Wen
    TRANSLATIONAL NEURODEGENERATION, 2022, 11 (01)
  • [25] High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease
    Macchi, Francesca
    Deleersnijder, Angelique
    Van den Haute, Chris
    Munck, Sebastian
    Pottel, Hans
    Michiels, Annelies
    Debyser, Zeger
    Gerard, Melanie
    Baekelandt, Veerle
    JOURNAL OF NEUROSCIENCE METHODS, 2016, 261 : 117 - 127
  • [26] Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson's disease
    Izco, Maria
    Blesa, Javier
    Verona, Guglielmo
    Cooper, J. Mark
    Alvarez-Erviti, Lydia
    NEUROSCIENCE RESEARCH, 2021, 170 : 330 - 340
  • [27] Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease
    Brembati, Viviana
    Faustini, Gaia
    Longhena, Francesca
    Outeiro, Tiago Fleming
    Bellucci, Arianna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [28] A Review of the Protective Effects of Alkaloids against Alpha-synuclein Toxicity in Parkinson's Disease
    Khodadadi, Mahdi
    Javadi, Behjat
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2025, 25 (02) : 112 - 127
  • [29] Aggregation of α-synuclein in the pathogenesis of Parkinson's disease
    Iwatsubo, T
    JOURNAL OF NEUROLOGY, 2003, 250 (Suppl 3) : 11 - 14
  • [30] Models of α-synuclein aggregation in Parkinson’s disease
    Rosa María Giráldez-Pérez
    Mónica Antolín-Vallespín
    María Dolores Muñoz
    Amelia Sánchez-Capelo
    Acta Neuropathologica Communications, 2